Masato Iwata

Title: Masato Iwata: Innovator in Anticoagulant Therapeutics

Introduction

Masato Iwata is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticoagulant agents. With a total of 2 patents, his work has the potential to impact therapeutic approaches to thrombosis.

Latest Patents

Iwata's latest patents include a compound known as (cycloalkyl-carbonyl)proline derivative. This compound exhibits excellent FXIa inhibitory activity and is useful as a therapeutic agent against thrombosis. The formula includes various components such as a three- to eight-membered hydrocarbon ring and optionally substituted amino Calkyl groups. His second patent involves condensed 5-oxazolidinone derivatives, which have excellent anticoagulant effects and are well absorbed orally. These compounds are also aimed at providing therapeutic solutions for thrombosis.

Career Highlights

Masato Iwata is currently associated with Sumitomo Dainippon Pharma Co., Ltd. His work in the pharmaceutical industry has been instrumental in advancing the development of new therapeutic agents. His innovative approach to drug design has garnered attention in the medical community.

Collaborations

Iwata has collaborated with notable colleagues such as Yohei Ikuma and Chongkwang Lee. These partnerships have contributed to the successful development of his patented compounds.

Conclusion

Masato Iwata's contributions to the field of anticoagulant therapeutics highlight his innovative spirit and dedication to improving medical treatments. His patents represent significant advancements in the fight against thrombosis, showcasing the importance of research and collaboration in the pharmaceutical industry.